| 1 Age, 1T PAPP‐A , 2T free ßhCG and 2T AFP at 5% FPR |
1 |
1188 |
| 2 Age, 1T PAPP‐A , 2T free ßhCG and 2T AFP, risk 1:300 |
1 |
1009 |
| 3 Age, 1T PAPP‐A , 2T total hCG, and 2T AFP at 5% FPR |
1 |
1188 |
| 4 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3 and 2T AFP at 5% FPR |
1 |
1188 |
| 5 Age, 1T PAPP‐A , 2T total hCG, 2T uE3 and 2T AFP at 2% FPR |
2 |
707 |
| 6 Age, 1T PAPP‐A , 2T total hCG, 2T uE3 and 2T AFP at 5% FPR |
2 |
1767 |
| 7 Age, 1T PAPP‐A , 2T total hCG, 2T uE3 and 2T AFP at risk 1:200 |
2 |
707 |
| 8 Age, 1T PAPP‐A , 2T total hCG, 2T uE3 and 2T AFP, mixed cutpoints |
4 |
2474 |
| 9 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at 5% FPR |
1 |
1188 |
| 10 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:50 |
1 |
1188 |
| 11 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:100 |
1 |
1188 |
| 12 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:150 |
1 |
1188 |
| 13 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:200 |
1 |
1188 |
| 14 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:250 |
1 |
1188 |
| 15 Age, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:300 |
1 |
1188 |
| 16 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A at 5% FPR |
2 |
34821 |
| 17 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:100 |
1 |
540 |
| 18 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:150 |
1 |
540 |
| 19 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:200 |
1 |
540 |
| 20 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A at risk 1:250 |
1 |
540 |
| 21 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A, mixed cutpoints |
3 |
35361 |
| 22 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T PAPP‐A at 2% FPR |
2 |
707 |
| 23 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T PAPP‐A at risk 1:200 |
2 |
707 |
| 24 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP, 2T Inhibin A and 2T PAPP‐A at risk 1:100 |
1 |
540 |
| 25 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP, 2T Inhibin A and 2T PAPP‐A at risk 1:150 |
1 |
540 |
| 26 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP, 2T Inhibin A and 2T PAPP‐A at risk 1:200 |
1 |
540 |
| 27 Age, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP, 2T Inhibin A and 2T PAPP‐A at risk 1:250 |
1 |
540 |
| 28 Age, 1T PAPP‐A , 1T total hCG, 2T total hCG, 2T uE3 and 2T AFP at 2% FPR |
2 |
707 |
| 29 Age, 1T PAPP‐A , 1T total hCG, 2T total hCG, 2T uE3 and 2T AFP at risk 1:200 |
2 |
707 |
| 30 Age, 1T PAPP‐A , 1T uE3, 2T total hCG, 2T uE3 and 2T AFP at 2% FPR |
2 |
707 |
| 31 Age, 1T PAPP‐A , 1T uE3, 2T total hCG, 2T uE3 and 2T AFP at risk 1:200 |
2 |
707 |
| 32 Age, 1T PAPP‐A , 1T total hCG, 1T uE3, 2T total hCG, 2T uE3, 2T AFP and 2T PAPP‐A at 2% FPR |
2 |
707 |
| 33 Age, 1T PAPP‐A , 1T total hCG, 1T uE3, 2T total hCG, 2T uE3, 2T AFP and 2T PAPP‐A at risk 1:200 |
2 |
707 |
| 34 Age, 1T AFP, 1T free ßhCG, 1T uE3, 2T total hCG, 2T uE3 and 2T AFP at risk 1:250 |
1 |
12339 |
| 35 Age, 1T AFP, 1T free ßhCG, 1T uE3, 2T total hCG, 2T uE3 and 2T AFP at risk 1:384 |
1 |
12339 |
| 36 Age, 1T NT, 2T total hCG and 2T AFP, 5FPR |
2 |
17347 |
| 37 Age, 1T NT, 2T total hCG and 2T AFP, risk 1:250 |
2 |
5446 |
| 38 Age, 1T NT, 2T total hCG and 2T AFP, mixture cutpoint |
4 |
22793 |
| 39 Age, 1T NT, 2T free ßhCG and 2T AFP, 5FPR |
2 |
6616 |
| 40 Age, 1T NT, 2T free ßhCG and 2T AFP, mixture cutpoint |
2 |
6616 |
| 41 Age, 1T NT, 2T free ßhCG, 2T uE3 and 2T AFP, 5FPR |
1 |
1110 |
| 42 Age, 1T NT, 2T total hCG, 2T uE3 and 2T AFP, 5FPR |
1 |
1110 |
| 43 Age, 1T NT, 2T total hCG, 2T uE3 and 2T AFP, risk 1:250 |
2 |
3256 |
| 44 Age, 1T NT, 2T total hCG, 2T uE3 and 2T AFP, mixture cutpoint |
4 |
13708 |
| 45 Age, 1T NT, 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A, 5FPR |
1 |
1110 |
| 46 Age, 1T NT, 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, 5FPR |
1 |
1110 |
| 47 Age, 1T NT, 2T free ßhCG, 2T uE3, 2T AFP and 1T PAPP‐A , 5FPR |
1 |
1110 |
| 48 Age, 1T NT, 2T free ßhCG, 2T uE3, 2T AFP and 1T PAPP‐A , risk 1:250 |
1 |
390 |
| 49 Age, 1T NT, 1T PAPP‐A , 2T total hCG and 2T AFP, 5FPR |
1 |
1110 |
| 50 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG and 2T AFP, 5FPR |
1 |
1110 |
| 51 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG and 2T AFP,risk 1:250 |
1 |
390 |
| 52 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG and 2T AFP, risk 1:300 |
1 |
2290 |
| 53 Age, 1T NT, 1T PAPP‐A, 2T total hCG, 2T uE3 and 2T AFP 5FPR |
1 |
1110 |
| 54 Age, 1T NT, 1T PAPP‐A , 2T total hCG, 2T uE3 and 2T AFP, risk 1:200 |
1 |
32227 |
| 55 Age, 1T NT, 1T PAPP‐A, 2T total hCG, 2T uE3 and 2T AFP, mixed cutpoints |
2 |
33337 |
| 56 Age, 1T NT, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A, 5FPR |
2 |
34743 |
| 57 Age, 1T NT, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A, risk 1:150 |
1 |
4927 |
| 58 Age, 1T NT, 1T PAPP‐A , 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A, mixed cutpoints |
3 |
39670 |
| 59 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:300 |
1 |
390 |
| 60 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, 1:270 |
1 |
7842 |
| 61 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:250 |
1 |
390 |
| 62 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:200 |
1 |
390 |
| 63 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:150 |
2 |
9759 |
| 64 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:100 |
1 |
390 |
| 65 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A,risk 1:50 |
1 |
390 |
| 66 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, 5FPR |
3 |
31698 |
| 67 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, 3FPR |
1 |
22746 |
| 68 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, 1FPR |
1 |
22746 |
| 69 Age, 1T NT, 1T PAPP‐A , 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A, mixed cutpoints |
4 |
40348 |
| 70 Age, 1T NT, 1T PAPP‐A, 1T free ßhCG, 2T total hCG, 2T uE3 and 2T AFP, risk 1:250 |
1 |
5060 |
| 71 Age, 1T NT, 1T PAPP‐A, 1T free ßhCG, 2T uE3, 2T AFP, 2T total hCG and 2T Inhibin A, risk 1:150 |
1 |
33546 |
| 72 ADAM 12 2T TO 1T RATIO |
1 |
579 |
| 73 Stepwise: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk <1/30, 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A risk 1:270 |
1 |
32355 |
| 74 Stepwise: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk <1/30, 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A risk 1:270 |
1 |
7842 |
| 75 Stepwise: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk <1/30, 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A 5% FPR |
1 |
7842 |
| 76 Stepwise: Age, 1T NT, 1T PAPP‐A , if risk <1:100, 2T free ßhCG, 2T uE3, 2T AFP, risk 1:250 |
1 |
1507 |
| 77 Contingent: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk 1/30‐1/1500, 2T total hCG, 2T uE3, 2T AFP and 2T Inhibin A risk 1:270 |
1 |
32355 |
| 78 Contingent: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk 1/30‐1/1500, 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A risk 1:270 |
1 |
7842 |
| 79 Contingent: Age, 1T NT, 1T PAPP‐A , 1T free ßhCG, if risk 1/30‐1/1500, 2T free ßhCG, 2T uE3, 2T AFP and 2T Inhibin A 5%FPR |
1 |
7842 |
